Basel Medical Group Ltd Ordinary Shares (BMGL) Earnings History
Net Loss4 years of earnings data (2021–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Basel Medical Group Ltd Ordinary Shares (BMGL) Earnings Overview
As of June 25, 2026, Basel Medical Group Ltd Ordinary Shares (BMGL) reported trailing twelve-month net income of -$12M, reflecting -554.5% year-over-year growth. The company earned $-5.16 per diluted share over the past four quarters, with a net profit margin of -106.8%.
Looking at the long-term picture, BMGL's historical earnings data spans multiple years. The company achieved its highest annual net income of $2M in fiscal 2023.
Basel Medical Group Ltd Ordinary Shares is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACMR ($91M net income, 10.4% margin), CLOV (-$57M net income, -4.4% margin), HCAI (N/A net income, -659.2% margin), BMGL has room to improve margins relative to the peer group. Compare BMGL vs ACMR →
BMGL Earnings vs Peers
Earnings metrics vs comparable public companies
BMGL Historical Earnings Data (2021–2024)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$12M | -683.2% | -$2M | $-5.16 | -106.8% | -19.3% |
| 2023 | $2M | +16.2% | $2M | $1.14 | 20.6% | 21.8% |
| 2022 | $2M | -9.8% | $2M | $0.96 | 18.4% | 20.6% |
| 2021 | $2M | - | $2M | $1.07 | 18.6% | 23.2% |
Download Data
Export BMGL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BMGL — Frequently Asked Questions
Quick answers to the most common questions about buying BMGL stock.
What is BMGL earnings per share (EPS)?
BMGL trailing twelve-month (TTM) diluted EPS is $-5.16, reflecting -554.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2024 is available in the table on this page.
What is Basel Medical Group Ltd Ordinary Shares's net income?
Basel Medical Group Ltd Ordinary Shares (BMGL) trailing twelve-month net income is $-12M as of 2024. Earnings declined -554.5% year-over-year.
Is BMGL profitable?
BMGL is not currently profitable on a TTM basis, reporting a net loss of $-12M. Net margin is -106.8%. Investors should monitor for a return to profitability.
What is BMGL's earnings growth rate?
BMGL compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2024.
What are BMGL's profit margins?
Basel Medical Group Ltd Ordinary Shares net profit margin is -106.8%, operating margin is -19.3%, and gross margin is +77.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -194.6%.
Is BMGL growing earnings?
BMGL earnings are declining — EPS fell -554.5% year-over-year. TTM net income dropped to $-12M. This contrasts with the 5-year CAGR of N/A.
What was BMGL's best earnings year?
Basel Medical Group Ltd Ordinary Shares's highest annual net income on record is $2M, achieved in fiscal year 2023. Earnings history on this page spans 2021 to 2024 and includes all annual and quarterly figures.
What were BMGL's earnings last quarter?
BMGL's most recent reported quarter was Q4 2024. Net income was $-10M with diluted EPS of $-0.52. For a full breakdown of all quarters, see the quarterly earnings table on this page.